Liz Szabo

1 month ago | nbcnews.com | Aria Bendix |Liz Szabo |Brandy Zadrozny

The measles outbreak in West Texas has reignited familiar anti-vaccine tactics: claiming there are readily available treatments for the disease while sowing doubt in the safety of vaccines. Health Secretary Robert F. Kennedy Jr. on Sunday touted two particular medications that have not been shown to work as first-line treatments for measles: the steroid budesonide and the antibiotic clarithromycin.

1 month ago | flipboard.com | Aria Bendix |Liz Szabo |Brandy Zadrozny

2 hours agoIn response to US President Donald Trump's massive levies on China, Beijing has not only imposed reciprocal tariffs of its own on US goods. It has also stopped the export of valuable rare earths which are crucial for many high-tech US industries.

1 month ago | nbcnews.com | Liz Szabo

Kelly Houske was walking her dogs one morning when she developed stabbing pain in her back that brought her to her knees. Houske, who had survived her first heart attack only a year earlier, was worried she was experiencing a second. When Houske arrived at a local emergency room by ambulance, she hoped for compassionate treatment. Instead, her doctor appeared cold and kept his distance, standing in the doorway without ever entering her room, Houske said.

1 month ago | nbcnews.com | Liz Szabo

As measles spreads across the country, sick children and adults are exposing other patients — including newborn babies — when they seek care at hospitals, pediatrician’s offices and urgent care centers. To help control the spread of measles, one of the medical experts say people with suspected cases should take precautions before visiting a doctor’s office or the emergency room.

1 month ago | telemundoarizona.com | Liz Szabo

El cáncer de cuello uterino es uno de los más prevenibles, aunque investigaciones recientes sugieren que Estados Unidos está retrocediendo en los esfuerzos para detectar la enfermedad en sus etapas iniciales, cuando es más curable. Un nuevo estudio muestra que el porcentaje de mujeres que se sometieron a pruebas de detección de cáncer de cuello uterino disminuyó del 47% en 2019 al 41% en 2023.